Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Name: Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)
Published: 2015
License: Public Domain

Medtronic Vascular · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

cardiovascular-diseases coronary-artery-disease

ischemic heart disease, cardiovascular diseases, arteriosclerosis, coronary artery disease, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Related documents